+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

The Market for Heart Benefit Foods - An International Global Analysis

  • ID: 35135
  • Report
  • March 2005
  • Region: Global
  • Leatherhead Research Ltd.
1 of 4
Heart-benefit foods is just one area of the international functional foods market, but one that has been developing strongly over the past few years in response to rising concern over the incidence of CVD, ongoing product and market development in heart-health ingredients such as phytosterols and omega-3 fatty acids, and regulatory developments, particularly in the key US market, that have allowed certain claims to be linked to particular foods and ingredients.

Since our 2001 Heart Benefit Foods report, activity in the area has accelerated strongly, with over 90 launches recorded over a 2-year period. At the same time, many of the market sectors that were in their infancy four years ago have now become established and are continuing to develop, segment and extend, while pioneering ingredients and technologies in the sector are now coming into standard use. This new edition will update you on recent developments, current trends and future prospects in this dynamic and evolving market. and associated ingredients technology.
Note: Product cover images may vary from those shown
2 of 4

Loading
LOADING...

3 of 4
LIST OF TABLES
LIST OF FIGURES

INTRODUCTION
Research Scope and Definitions
Research Method
Information Provided
Currency Conversions

1. EXECUTIVE SUMMARY
1.1 Market Size and Segmentation
1.2 Key Market Drivers
1.3 Innovation and New Product Development
1.4 The Regulatory Environment
1.5 Industry Dynamics
1.6 Future Prospects

2. MARKET SITUATION
2.1 Overview
2.2 Fats and Oils
2.2.1 Overview
2.2.2 Europe
2.2.3 US
2.2.4 Japan
2.2.5 Australia
2.3 Cereal Products
2.3.1 Overview
2.3.2 Europe
2.3.3 US
2.3.4 Japan
2.3.5 Australia
2.4 Soya Products
2.4.1 Overview
2.4.2 Europe
2.4.3 US
2.4.4 Japan
2.4.5 Australia
2.5 Dairy Products
2.5.1 Overview
2.5.2 Europe
2.5.3 US
2.5.4 Japan
2.5.5 Australia
2.6 Eggs
2.6.1 Overview
2.6.2 Europe
2.6.3 US
2.6.4 Japan
2.6.5 Australia
2.7 Bakery Products
2.7.1 Overview
2.7.2 Europe
2.7.3 US
2.7.4 Japan
2.7.5 Australia
2.8 Soft Drinks
2.8.1 Overview
2.8.2 Europe
2.8.3 US
2.8.4 Japan
2.8.5 Australia

3. PRODUCT TRENDS
3.1 Overview
3.1.1 Overview
3.1.2 Europe
3.1.3 US
3.1.4 Japan
3.1.5 Australia
3.2 Cholesterol-lowering Foods and Drinks
3.2.1 Phytosterols/phytostanols
3.2.2 Soya protein
3.2.3 Oat bran/beta-glucan
3.2.4 Psyllium
3.2.5 Wholegrains
3.3 Circulatory Health Foods and Drinks
3.3.1 Omega-3/DHA
3.4 Anti-hypertensive Foods and Drinks
3.4.1 Bioactive peptides
3.4.2 Potassium
3.5 Antioxidant Heart Health Foods and Drinks

4. HEART AND CIRCULATORY DISEASE
4.1 Summary
4.2 Prevalence by Country and Trends in Incidence
4.2.1 Variation in circulatory disease death rates across countries
4.2.2 Influence of gender and age on death rates from circulatory disease
4.2.3 Variation in hypertensive disease death rates across countries
4.2.4 Death rates from cerebrovascular disease
4.3 Background to Cardiovascular Disease (CVD)
4.3.1 Development of cardiovascular disease
4.4 Summary of Risk Factors
4.4.1 Types of evidence
4.4.2 Categories of risk factors for coronary heart disease (CHD)
4.4.3 Controllable risk factors – physiological
4.4.4 Lifestyle
4.4.5 Uncontrollable risk factors
4.4.6 Early development
4.4.7 Medical conditions that increase risk of CHD
4.4.8 Prevention
4.5 References
4.6 Further Reading

5. EFFECT OF DIET: CURRENT AND POTENTIAL HEART HEALTH INGREDIENTS
5.1 Summary
5.2 Principal Heart Health Dietary Factors
5.2.1 Soya
5.2.2 Unsaturated fatty acids
5.2.3 Phytostanol and phytosterol esters
5.2.4 Dietary fibre
5.2.5 Antioxidant vitamins E and C
5.2.6 Folic acid
5.2.7 Potassium-based salt replacers
5.3 Other Up-and-coming Heart Health Ingredients
5.3.1 Carotenoids
5.3.2 Vitamins B6 and B12
5.3.3 Vitamin B3 (niacin)
5.3.4 Garlic
5.3.5 Antioxidant polyphenols and flavonoids
5.3.6 L-arginine
5.3.7 Magnesium
5.3.8 Bioactive peptides
5.3.9 Chitosan
5.3.10 Wholegrains
5.4 Less Well-proven Ingredients
5.4.1 Conjugated linoleic acid
5.4.2 Plant lignans
5.4.3 Rice bean oil (contains sterols, tocotrienols gamma-oryzanol)
5.4.4 Coenzyme Q10
5.4.5 Betaine
5.4.6 Selenium
5.5 References
5.6 Further Reading

6. PATENT REVIEW
6.1 Summary
6.2 Cholesterol-lowering Products
6.2.1 Phytosterols and phytostanols
6.2.2 Cholesterol-lowering soya protein products
6.2.3 Soluble fibre
6.3 Circulatory Health
6.3.1 PUFA-containing products
6.4 Anti-hypertensives
6.4.1 Anti-hypertensive compilations
6.4.2 Anti-hypertensive bioactive peptides
6.5 Multiple-benefit and Miscellaneous Heart-health Products
6.6 Polyphenols and Flavonoids

7. HEART HEALTH INGREDIENTS – PROPERTIES AND AVAILABILITY
7.1 Ingredients (A-Z)
7.1.1 Antioxidant vitamins
7.1.2 Antioxidant polyphenols and flavonoids
7.1.3 Arginine
7.1.4 B vitamins
7.1.5 Beta-glucan
7.1.6 Betaine
7.1.7 Bioactive peptides
7.1.8 Carotenoids
7.1.9 Chitosan
7.1.10 Coenzyme Q10
7.1.11 Conjugated linoleic acid
7.1.12 Dietary fibre
7.1.13 Fibre
7.1.14 Flaxseed
7.1.15 Folic acid
7.1.16 Garlic
7.1.17 Isoflavones
7.1.18 Lactic acid bacteria
7.1.19 Linseed
7.1.20 Magnesium
7.1.21 Monounsaturated fatty acids (MUFAs)
7.1.22 Mushroom nutraceuticals
7.1.23 Omega-3 polyunsaturated fatty acids
7.1.24 Phytochemicals
7.1.25 Phytosterol and phytostanol esters
7.1.26 Psyllium
7.1.27 Rice bran oil
7.1.28 Salt substitutes
7.1.29 Saponins
7.1.30 Soya
7.1.31 Tocotrienols
7.1.32 Vitamins
7.1.33 Ubiquinone
7.2 Useful Web Directories for Ingredients Suppliers

APPENDIX 1 COLOUR PLATES

LIST OF TABLES
Table 1.I Heart Benefit Foods Market Development, 2004-2009
Table 1.II Heart Benefit Fats and Oils – Global Market Prospects Summary
Table 1.III Heart Benefit Cereal Products – Global Market Prospects Summary
Table 1.IV Heart Benefit Soya Products – Global Market Prospects Summary
Table 1.V Heart Benefit Dairy Products – Global Market Prospects Summary
Table 1.VI Heart Benefit Eggs – Global Market Prospects Summary
Table 1.VII Heart Benefit Bakery Products – Global Market Prospects Summary
Table 1.VIII Heart Benefit Soft Drinks – Global Market Prospects Summary
Table 2.I Heart Benefit Foods - Market Trends by Country, 2004-2005
Table 2.II Heart Benefit Foods - Market Trends by Type of Products, 2004-2005
Table 2.III Heart Benefit Fats and Oils – Market Trends by Country, 2004-2005
Table 2.IV Phytosterol/Phytostanol spreads – Key Brands, 2005
Table 2.V France: Anti-cholesterol Margarine Market by Volume and Value, 2001-2004
Table 2.VI France: Anti-cholesterol Margarine Brand Shares, 2004
Table 2.VII UK: Yellow Fats Market by Type, 2004
Table 2.VIII Australia: Margarine Market by Type, 2004
Table 2.IX Australia: Cholesterol-lowering Margarine Market by Volume and Value, 1999-2004
Table 2.X Heart Benefit Cereal Products – Market Trends by Country, 2004-2005
Table 2.XI US: Leading RTE Breakfast Cereal Brands, 2004
Table 2.XII Australia: Breakfast Cereals Market by Type, 2004
Table 2.XIII Heart Benefit Soya Products – Market Trends by Country, 2004-2005
Table 2.XIV Soya Milks Market by Selected Country, 2004
Table 2.XV UK: Soya Milks Market by Value, 1995-2004
Table 2.XVI Australia: Soya Milks Market by Volume and Value, 2000-2004
Table 2.XVII Australia: Soya Milks Market Shares by Type, 2004
Table 2.XVIII Heart Benefit Dairy Products – Market Trends by Country, 2004-2005
Table 2.XIX France: Heart Benefit Dairy Products Market by Type, 2004
Table 2.XX France: Anti-cholesterol Yoghurts Brand shares, 2004
Table 2.XXI Spain: Heart Benefit Dairy Products Market by Type, 2004
Table 2.XXII UK: Heart Benefit Dairy Products Market by Type, 2004
Table 2.XXIII Heart Benefit Eggs – Market Trends by Country, 2004-2005
Table 2.XXIV Heart Benefit Bakery Products – Market Trends by Country, 2004-2005
Table 2.XXV Heart Benefit Soft Drinks - Market Trends by Country, 2004-2005
Table 3.1 Cholesterol-lowering Foods and Drinks: New Product Activity, 2003-2005
Table 3.II Circulatory Health Foods and Drinks: New Product Activity, 2004-2005
Table 3.III Anti-hypertensive Foods and Drinks: New Product Activity, 2003-2005
Table 3.IV Antioxidant Heart Health Foods and Drinks: New Product Activity, 2003-2005
Table 4.I Number of Registered Death Rates for all Causes of Death and
Deaths by Diseases of the Circulatory System per 100,000 Population by Country, Year and Gender
Table 4.II Number of Registered Death Rates for all Causes of Death and
Deaths by Diseases of the Circulatory System per 100,000 Population by Country, Year and Gender
Table 4.III Number of Registered Death Rates for all Causes of Death and
Deaths by Diseases of the Circulatory System per 100,000 Population by Age Group and Gender, 2002
Table 4.IV Number of Registered Death Rates from Hypertensive Disease per 100,000 Population by Country, Year and Gender
Table 4.V Number of Registered Death Rates from Hypertensive Disease per
100,000 Population by Country, Year and Gender
Table 4.VI Number of Registered Death Rates from Cerebrovascular Disease per 100,000 Population by Country, Year and Gender
Table 4.VII Number of Registered Death Rates from Cerebrovascular Disease per 100,000 Population by Country, Year and Gender
Table 4.VIII Development of Cardiovascular Disease per 100,000 Population by Country, Year and Gender
Table 4.IX Study Methods to Determine Risk and Causal Factors
Table 4.X Risk Factors for Coronary Heart Disease (CHD)
Table 4.XI Relationship Between Blood Cholesterol Level and Risk of Coronary Heart Disease
Table 4.XII Classification of Plasma Lipoproteins
Table 4.XIII Examples of Antioxidant Defences
Table 4.XIV Blood Pressure Categories
Table 4.XV Summary of the Interrelation Between Diet and Physiological Risk Factors for Coronary Heart Disease
Table 4.XVI Genetic Disorders Relevant to Coronary Heart Disease
Table 4.XVII Principles of Prevention Strategies for Coronary Heart Disease
Table 4.XVIII Dietary Recommendations (Population Averages) for the Prevention of Coronary Heart Disease
Table 5.I Beneficial Effects of the n-3 Fatty Acids: EPA and DHA
Table 6.I Other Patents Relating to Phytostanols and Phytosterols
Table 6.II Other Patents Relating to Cholesterol-lowering Soya Products
Table 6.III Other Patents Relating to Soluble Fibre
Table 6.IV Other Patents Relating to Polyunsaturated Fatty Acids
Table 6.V Other Patents Relating to Anti-hypertensives
Table 6.VI Other Patents Relating to Bioactive Anti-hypertensive Peptides
Table 6.VII Other Patents Relating to Miscellaneous Heart-health Products
Table 6.VIII Other Patents Relating to Polyphenols and Flavonoids

LIST OF FIGURES
Figure 1 Heart Benefit Foods Market by Country, 2004
Figure 2 Heart Benefit Foods Market by Product Type, 2004
Figure 3 Plaque Formation
Figure 4 Processes Involved in Blood Clotting
Figure 5 Production of Homocysteine
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll